An Imaging Study for Patients with Non-Alcoholic Steatohepatitis

Clinical Trial Title

Non-invasive quantification of liver health in NASH (N-QUAN): A prospective diagnostic accuracy study

National Clinical Trial Number:


Contact Information

Clinical Trial Protocol Description:

This simple study investigates how a new MRI technology (LiverMultiscan software) is able to identify patients with a NAFLD activity score (NAS) ≥ 4 and liver fibrosis ≥ stage 2, compared to the histopathologic reference standard.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have non-alcoholic steatohepatitis (NASH).
  • Have a standard of care liver biopsy ordered by your physician.

You will be excluded from the study if any of the following criteria apply to you:

  • Have had NASH diagnosed with a liver biopsy within the previous 5 years.
  • Have a history or diagnosis of cirrhosis and/or hepatic decompensation including ascites, hepatic encephalopathy or variceal bleeding.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Nancy Reau, MD

Contact Information

Diana Goldman

Clinical Trial Location

RUSH University Medical Center


RUSH University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more